https://www.pharmadoc.it/wp-content/uploads/2020/10/Tribunale-Europeo.jpg
1210
1774
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-10-05 11:42:562021-09-07 18:03:42Si puó restare orfani per sempre? Rispetto a quale comparator? E come off-label? Anche nel RCP? Il tribunale europeo prova a fare chiarezza
https://www.pharmadoc.it/wp-content/uploads/2020/09/burden-of-proof.jpg
1296
2067
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-09-25 08:09:442021-09-07 15:57:26Inversione dell’onere della prova a carico di AIFA
https://www.pharmadoc.it/wp-content/uploads/2020/09/Equivalenza-Terapeutica-1.jpg
1280
1596
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2020-09-03 12:26:422022-05-05 15:48:23Nell’equivalenza terapeutica non c’è inversione dell’onere della prova
https://www.pharmadoc.it/wp-content/uploads/2019/09/farmaci-orfani-2.jpg
1281
1920
rossana
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
rossana2019-09-20 12:31:072019-09-23 12:19:00Designazione orfana: la diversità di eccipienti quale elemento distintivo tra medicinali
https://www.pharmadoc.it/wp-content/uploads/2019/02/shutterstock_248156353.jpg
1200
1600
webadmin
https://www.pharmadoc.it/wp-content/uploads/2020/12/pharmadoc-logo.png
webadmin2019-02-20 12:14:582020-10-15 12:43:21Tipologie distributive dei farmaci e obiettivi di governance